Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance

Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Cao, Yiting, Lathia, Justin D., Eyler, Christine E., Wu, Qiulian, Li, Zhizhong, Wang, Hui, McLendon, Roger E., Hjelmeland, Anita B., Rich, Jeremy N.
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2010
Предметы:
Original Articles and Short Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/
https://ncbi.nlm.nih.gov/pubmed/20657792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы